Esophagectomy is pivotal for the long-term survival in patients with early stage and advanced esophageal cancer, and improved perioperative care and advanced surgical techniques have contributed to reduced postoperative morbidity. However, despite these advances, esophagectomy continues to be associated with significant morbidity and mortality. Minimally invasive esophageal surgery (MIE) has been increasingly used in patients undergoing surgery for esophageal cancer. Potential advantages of MIE include the decreased postoperative pain; lower postoperative wound infection, decreased pulmonary complications, and decreased length of hospitalization. Robotic esophageal surgery has the ability to overcome some of the limitations of laparoscopic and thoracoscopic approaches to esophagectomy while maintaining the benefits of the minimally invasive approach. In this article, we will review the clinical efficacy and outcomes associated with robotic-assisted Ivor Lewis esophagectomy (RAIL).
Keyphrases
- minimally invasive
- robot assisted
- patients undergoing
- early stage
- postoperative pain
- healthcare
- palliative care
- pulmonary hypertension
- type diabetes
- coronary artery bypass
- radiation therapy
- cardiac surgery
- adipose tissue
- metabolic syndrome
- quality improvement
- skeletal muscle
- lymph node
- percutaneous coronary intervention
- pain management
- wound healing
- climate change
- affordable care act